PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinical Research Development Unit of Rohani Hospital, Babol University of Medical Sciences, Ganjafrooz Ave, Babol, Iran. behnaz_ghahari@yahoo.com.\', \'Babol University of Medical Sciences, Babol, Iran.\', \'Clinical Research Development Unit of Rohani Hospital, Babol University of Medical Sciences, Ganjafrooz Ave, Babol, Iran.\', \'Razi Labratory, Babol, Iran.\', \'Wilfrid Laurier University, Waterloo, Canada.\', \'Institute of Structronics, Ottawa, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s10067-021-05779-4
?:doi
?:hasPublicationType
?:journal
  • Clinical rheumatology
is ?:pmid of
?:pmid
?:pmid
  • 34052904
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.93
?:rankingScore_hIndex
  • 71
is ?:relation_isRelatedTo_publication of
?:title
  • Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34052904>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34052904>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all